SubjectWell peer-reviewed paper shows major diagnostic gap in dysmenorrhea

A real-world evidence study published in JMIR reports results on a survey of 3,546 women in Germany, Austria, and Poland showing high pain burden but low diagnosis rates; targeted online campaigns demonstrated strong ability to engage affected, often undiagnosed, populations
How to avoid ineligible patient referrals in clinical trials

Ineligible referrals waste time and resources. See how SubjectWell improves referral quality with smarter screening, site support, and patient-first engagement.
SubjectWell announces Steve Ciske as new Chief Technology Officer

Steve will will drive innovation and AI strategy, while strengthening security and compliance to advance SubjectWell’s Patient Experience Platform.
The Power of Digital Patient Recruitment in Mental Health Trials

Dr. Matthias Roos, Director of Scientific Affairs at SubjectWell, discusses his latest research in recruiting underrepresented patient populations in depression trials.
Patient Recruitment: Digital, Design, Data and Dedicated Support to Reach the Unreachable

Learn how digital, design, data, and dedicated support can turn hard-to-reach patients into engaged clinical trial participants.
The missing piece in your patient recruitment platform

How real-time dashboards and instant access to medical records can reduce screening delays and improve enrollment efficiency.
SubjectWell appoints veteran healthcare finance leader Karl Stubelis as Chief Financial Officer

SubjectWell welcomes veteran healthcare finance leader Karl Stubelis as CFO to help scale global growth and accelerate patient recruitment.
Accelerating patient-centric clinical trials

A four-part framework on how strategy, science, support, and creative can drive faster, more effective studies
Where Do Clinical Trials Fail First? Inside the Cost of Recruitment Delays

SubjectWell CEO Fred Martin speaks with PharmaTech News on why many studies struggle to enroll the required number of eligible participants on schedule, and what that means for trial success.